|
OMA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.776000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.004600E-01 |
| Normal-vs-Stage2 |
1.648800E-01 |
| Normal-vs-Stage3 |
4.580000E-02 |
| Normal-vs-Stage4 |
9.712000E-01 |
| Stage1-vs-Stage2 |
4.877900E-02 |
| Stage1-vs-Stage3 |
3.561500E-03 |
| Stage1-vs-Stage4 |
6.549800E-01 |
| Stage2-vs-Stage3 |
8.408600E-01 |
| Stage2-vs-Stage4 |
1.923390E-01 |
| Stage3-vs-Stage4 |
7.606100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.057600E-01 |
| Normal-vs-AfricanAmerican |
4.133200E-01 |
| Normal-vs-Asian |
5.219600E-01 |
| Caucasian-vs-AfricanAmerican |
5.508200E-01 |
| Caucasian-vs-Asian |
2.977400E-01 |
| AfricanAmerican-vs-Asian |
2.450000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.382390E-01 |
| Normal-vs-Female |
9.204600E-01 |
| Male-vs-Female |
7.024300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.007000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.157000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.504360E-01 |
| Normal-vs-Age(81-100Yrs) |
1.831960E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.725000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.156500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.264400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.524800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.329200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.555600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.061600E-01 |
| Classical-VS-Follicular |
3.243700E-02 |
| Classical-VS-Other |
6.826000E-01 |
| Classical-VS-Normal |
4.925400E-01 |
| Tall-VS-Follicular |
6.519800E-01 |
| Tall-VS-Other |
9.055000E-01 |
| Tall-VS-Normal |
5.457400E-01 |
| Follicular-VS-Other |
7.314400E-01 |
| Follicular-VS-Normal |
1.823410E-01 |
| Other-VS-Normal |
8.133200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.898000E-01 |
| Normal-vs-N1 |
6.111000E-01 |
| N0-vs-N1 |
8.315400E-01 |
|
|
